Key result
Protocol outlines a systematic review evaluating depression prevalence and risk factors in lung cancer.
Why the study?
Patients with lung cancer often experience depression leading to poorer quality of life, shorter survival time, and greater mortality, prompting a summary of its prevalence and risk factors.
What is the prevalence and what are the risk factors of depression in patients with lung cancer?
Population
Patients with lung cancer
Design
Systematic review and meta-analysis protocol
Authors
Loading...
Prevalence and risk factors of depression in lung cancer remain unquantified; this protocol will deliver the first comprehensive synthesis to guide screening.
Systematic Review
What is the prevalence and what are the risk factors of depression in patients with lung cancer?
This is a protocol for a systematic review and meta-analysis to determine the prevalence and risk factors of depression in patients with lung cancer.
Yan et al. (2019) conducted a systematic review in Lung cancer and depression. Risk factors of depression was evaluated on Prevalence and risk factors of depression. This is a protocol for a systematic review and meta-analysis to evaluate the prevalence and risk factors of depression in patients with lung cancer; no results are reported.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: